These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6220640)

  • 41. Purification and reconstruction of the calcium, magnesium ATPase of the erythrocyte membrane.
    Carafoli E; Niggli V; Penniston JT
    Ann N Y Acad Sci; 1980; 358():159-68. PubMed ID: 6452081
    [No Abstract]   [Full Text] [Related]  

  • 42. A protein inhibitor of erythrocyte membrane (Ca2+ + Mg2+)-ATPase.
    Lee KS; Au KS
    Biochim Biophys Acta; 1983 Jan; 742(1):54-62. PubMed ID: 6130792
    [No Abstract]   [Full Text] [Related]  

  • 43. Phospholipid-protein interactions of the plasma-membrane Ca2+-transporting ATPase. Evidence for a tissue-dependent functional difference.
    Missiaen L; Raeymaekers L; Wuytack F; Vrolix M; de Smedt H; Casteels R
    Biochem J; 1989 Nov; 263(3):687-94. PubMed ID: 2532005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of membrane cholesterol depletion upon erythrocyte membrane-bound enzymes.
    Vickers JD; Rathbone MP
    Can J Biochem; 1979 Sep; 57(9):1144-52. PubMed ID: 228825
    [No Abstract]   [Full Text] [Related]  

  • 45. Asymmetric manipulation of the membrane lipid bilayer of intact human erythrocytes with phospholipase A, C, or D induces a change in cell shape.
    Fujii T; Tamura A
    J Biochem; 1979 Nov; 86(5):1345-52. PubMed ID: 521437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of blocking amino group couples on the mechanism of Mg and (Ca + Mg) ATPase associated with erythrocyte membrane fragments.
    Ballestrin G; Boninsegna A; Branca D; Scutari G
    Boll Soc Ital Biol Sper; 1982 Dec; 58(24):1603-7. PubMed ID: 6132611
    [No Abstract]   [Full Text] [Related]  

  • 47. The lipid requirement of the (Ca2+ + Mg2+)-ATPase in the human erythrocyte membrane, as studied by various highly purified phospholipases.
    Roelofsen B; Schatzmann HJ
    Biochim Biophys Acta; 1977 Jan; 464(1):17-36. PubMed ID: 137746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The control by Ca2+ of the polyphosphoinositide phosphodiesterase and the Ca2+-pump ATPase in human erythrocytes.
    Downes CP; Michell RH
    Biochem J; 1982 Jan; 202(1):53-8. PubMed ID: 6282272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of tightly bound phospholipid in the activity of erythrocyte acetylcholinesterase.
    Beauregard G; Roufogalis BD
    Biochem Biophys Res Commun; 1977 Jul; 77(1):211-9. PubMed ID: 883974
    [No Abstract]   [Full Text] [Related]  

  • 50. [The function of membrane Ca-ATPases and nonenzymatic peroxidation of membrane lipids in patients with hypertension].
    Siurin AA; Kulagin IuI; Anikin EI; Prokhoda AF; Kabeliuzhenko SB; Shcherbina LI
    Vopr Med Khim; 1990; 36(3):69-71. PubMed ID: 2143337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biochemical characterization of segreated membrane vesicles from human erythrocytes with increased intracellular Ca2+.
    Weidekamm E; Brdiczka D; Di Pauli G; Wildermuth M
    Arch Biochem Biophys; 1977 Mar; 179(2):486-94. PubMed ID: 851355
    [No Abstract]   [Full Text] [Related]  

  • 52. Erythrocyte membrane Ca2+-pumping ATPase of hypertensive humans: reduced stimulation by calmodulin.
    Olorunsogo OO; Okudolo BE; Lawal SO; Falase AO
    Biosci Rep; 1985 Jun; 5(6):525-31. PubMed ID: 2931136
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of the erythrocyte (Ca2+ + Mg2+)-ATPase by nonheme iron.
    Leclerc L; Marden M; Poyart C
    Biochim Biophys Acta; 1991 Feb; 1062(1):35-8. PubMed ID: 1825610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The nature of the Ca2+-pump defect in the red blood cells of patients with cystic fibrosis.
    Muallem S; Miner C; Seymour CA
    Biochim Biophys Acta; 1985 Sep; 819(1):143-7. PubMed ID: 2931115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of human erythrocyte Ca2+-dependent Mg2+-activated ATPase by calmodulin and calcium: quantitative analysis.
    Cox JA; Comte M; Stein EA
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4265-9. PubMed ID: 6126873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The activity of transport ATPases and the characteristics of the protein-lipid composition of the membranes of anuclear erythrocytes in a number of mammals].
    Matskevich IuA; Kazennov AM; Maslova MN
    Zh Evol Biokhim Fiziol; 1994; 30(4):497-504. PubMed ID: 7863741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nature of the (Ca2+ + Mg2+)-ATPase activator protein which associates with human erythrocyte membranes.
    Au KS; Chan BL
    Biochim Biophys Acta; 1982 Sep; 690(2):261-8. PubMed ID: 6127106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythrocyte membranes in biliary obstruction: phospholipase A2-induced alterations in lipid composition and morphology.
    Okano Y; Iida H; Takahashi M; Sekiya T; Hasegawa I; Nozawa Y
    Biochem Med; 1981 Dec; 26(3):314-25. PubMed ID: 7332542
    [No Abstract]   [Full Text] [Related]  

  • 59. Rabbit platelet calcium ATPase differs from the human erythrocyte (Ca2+ + Mg2+)-ATPase in its response to three purified phospholipases A2, exogenous phospholipids and calmodulin.
    Mostafa MH; Nelson DR; Shukla SD; Hanahan DJ
    Biochim Biophys Acta; 1984 Oct; 776(2):259-66. PubMed ID: 6148104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucose transport into human erythrocytes treated with phospholipase A2 or C.
    Fujii H; Miwa I; Okuda J; Tamura A; Fujii T
    Biochim Biophys Acta; 1986 Aug; 883(1):77-82. PubMed ID: 3730428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.